CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $)	3 Months Ended		59 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Research and Development Expense
Stock option expense	$ 17,406	$ 15,205	$ 386,761
Amortization expenses	48,109	51,756	839,572
Technology impairment charge			345,000
General and Administrative Expense
Stock option expense	1,950	104,726
Stock option and warrant expense			2,582,964
Stock for services			$ 300,000